Benzetimide Hydrochloride is a muscarinic acetylcholine receptor antagonist that has been investigated as an antiparkinsonian agent for the management of Parkinson’s disease and as a treatment for diarrhea.… Read more
Benzetimide Hydrochloride is a muscarinic acetylcholine receptor antagonist that has been investigated as an antiparkinsonian agent for the management of Parkinson’s disease and as a treatment for diarrhea. By blocking cholinergic receptors, this compound helps reduce tremors and improve motor control, making the availability of high-quality analytical standards essential for pharmaceutical research. This category provides access to Benzetimide Hydrochloride reference standards, as well as related impurities and stable isotope-labelled compounds, which are critical for accurate impurity profiling and quantitative analysis. Pharmaceutical laboratories rely on these characterized materials to support rigorous method validation, routine quality control testing, and regulatory compliance. Whether developing new formulations or conducting stability studies, researchers utilize these precise standards to ensure the integrity and safety of pharmaceutical products throughout the development lifecycle.